Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression

International Journal of Infectious Diseases

Volumn 95, Issue , 2020, Pages 183-191

  Liu, Fang ^a   Xu, Aifang ^a   Zhang, Yan ^a,b   Xuan, Weiling ^a   Yan, Tingbo ^a   Pan, Kenv ^a   Yu, Wenyan ^a   Zhang, Jun ^b  

^a Hangzhou Xixi Hospital   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

2019 Coronavirus disease; Asymptomatic infection; Eosinophil; Lopinavir

Indexed keywords

ALBUMIN; ALPHA2B INTERFERON; ARBIDOL; BILIRUBIN; C REACTIVE PROTEIN; CREATINE KINASE; CREATININE; HUMAN ALBUMIN; HUMAN IMMUNOGLOBULIN; LOPINAVIR; METHYLPREDNISOLONE; METOPROLOL; NIFEDIPINE; PANTOPRAZOLE; POTASSIUM; TENOFOVIR; TROPONIN I; VIRUS RNA;

ADULT; ALBUMIN BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ANTIVIRAL THERAPY; ARTICLE; ASYMPTOMATIC INFECTION; BILIRUBIN BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OUTCOME; COMBINATION DRUG THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CORONAVIRUS DISEASE 2019; COUGHING; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DETERIORATION; DIARRHEA; DISEASE EXACERBATION; DRUG WITHDRAWAL; EOSINOPHIL COUNT; FEMALE; FEVER; FLUORESCENCE QUANTITATIVE POLYMERASE CHAIN REACTION; HEADACHE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; HYPOKALEMIA; HYPOPROTEINEMIA; INCUBATION TIME; LUNG CONGESTION; LYMPHOCYTE COUNT; MALE; NAUSEA; NEBULIZATION; NOSE SMEAR; PLEURA EFFUSION; POTASSIUM BLOOD LEVEL; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SIDE EFFECT; SORE THROAT; THORAX RADIOGRAPHY; THROAT CULTURE; VIRAL CLEARANCE; VIRUS LOAD; VOMITING; BETACORONAVIRUS; BLOOD; CORONAVIRUS INFECTION; EOSINOPHIL; MIDDLE AGED; PANDEMIC; VIRUS PNEUMONIA;

BETACORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; EOSINOPHILS; FEMALE; HUMANS; LOPINAVIR; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL;

EID: 85083235914     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2020.03.013     Document Type: Article

References (12)

1. Chan, J.F.-W., Yuan, S., Kok, K.-H., To, K.K.-W., Chu, H., Yang, J., et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020.
2. Dous, G.V., Grigos, A.C., Grodman, R., Elevated troponin in patients with acute stroke–is it a true heart attack?. Egypt Heart J 69:3 (2017), 165–170.
3. Dybul, M., Fauci, A.S., Bartlett, J.G., Kaplan, J.E., Pau, A.K., Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV*. Ann Intern Med 51:RR-7 (2002), 1–55.
4. Hamp, D.B., Leženić, R., Duper, H.M., Goranović, T., Respiratory failure as a result of chronic impaired ventilation in actualization of insufficient respiration: a case report. Trends Anaesth Crit Care 16 (2017), 32–33.
5. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020.
6. Kellum, J.A., Lameire, N., Aspelin, P., Barsoum, R.S., Burdmann, E.A., Goldstein, S.L., et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1 (2012), 1–138.
7. National Health Commission, Tracking the epidemic. 2020, China CDC weekly, Beijing Available from: http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm#NHCJan27 [accessed 27.01.20].
8. The 2019-nCoV Outbreak Joint Field Epidemiology Investigation Team, Li, Q., An outbreak of NCIP (2019-nCoV) infection in China — Wuhan, Hubei Province, 2019–2020. China CDC Wkly 2:5 (2020), 79–80.
9. Touma, E., Bisharat, N., Trends in admission serum albumin and mortality in patients with hospital readmission. Int J Clin Pract, 73(6), 2019, e13314.
10. World Health Organization, Infection prevention and control during health care when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020, The Organization, Geneva Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 [accessed 27.01.20].
11. Wang, J.T., Wang-Huei, S., Chi-Tai, F., Yee-Chun, C., Jiun-Ling, W., Chong-Jen, Y., et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis 10:5 (2004), 818–824.
12. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA, 2020.